JENNIFER EUBANK

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant WASHINGTON, DC NPI 1669555652

General Payments — all program years on this page

$1,825.92

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 75
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $495.45 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $396.4518
Education $99.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $461.1321
2022 $450.7114
2023 $418.6321
2024 $495.4519

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078388374 Janssen Biotech, Inc. $19.09 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078388425 Janssen Biotech, Inc. $7.84 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078389363 Janssen Biotech, Inc. $99.00 05/23/2024 Education Undisputed 01/23/2026 View at CMS
1078389779 Janssen Biotech, Inc. $21.97 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086929027 Novartis Pharmaceuticals Corporation $25.93 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086929033 Novartis Pharmaceuticals Corporation $31.62 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101802234 E.R. Squibb & Sons, L.L.C. $20.94 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101802426 E.R. Squibb & Sons, L.L.C. $20.33 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107081856 ABBVIE INC. $18.99 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139927891 GENZYME CORPORATION $23.52 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139927907 GENZYME CORPORATION $33.90 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139927913 GENZYME CORPORATION $15.09 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141263625 Incyte Corporation $22.95 04/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141305713 Incyte Corporation $23.14 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141314167 Incyte Corporation $28.70 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145356299 Galderma Laboratories, L.P. $21.10 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145356301 Galderma Laboratories, L.P. $23.21 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147439606 Blueprint Medicines Corporation $24.75 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153824371 Ortho Dermatologics, a division of Bausch Health US, LLC $13.38 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.